PubMed Health⌕ Search

PubMed · 2498933

Environment-specific tolerance to nicotine.

Abstract

Research has shown that tolerance to the behavioral effects of numerous drugs is mediated by learning. The present study was designed to test whether animals develop tolerance to the antinociceptive effects of nicotine, and whether these effects are also learned. Rats were given dally injections of nicotine in the same environment. After each injection, the latency of tail withdrawal from a hot water bath was measured. This was continued until they were tolerant to the drug: i.e., their response latencies did not differ from animals repeatedly given saline. The role of learning in nicotine tolerance was assessed by changing the environment in which they received nicotine on the day after tolerance was achieved. When the drug environment was changed, the animals recovered the full dose effect of nicotine on tail-flick latencies. These results show that tolerance develops to nicotine's antinociceptive effects, and that this tolerance also may be influenced by learning.

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

L H Epstein, A R Caggiula, R Stiller. 1989. Environment-specific tolerance to nicotine.. https://doi.org/10.1007/bf00442256

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

Analgesic activity of a polysaccharide in experimental osteoarthritis in rats.

Viscosupplementation efficacy has been related to the high molecular weight of hyaluronic acid-like compounds, as well as to gel formulation. We evaluated the effect of a galactomannan polysaccharide derived from Guar gum (GG) in joint pain in an osteoarthritis (OA) model. Wistar rats (six animals/group) were subjected to anterior cruciate ligament transection (ACLT-OA group). The OA group was compared to a false-operated group (sham). Joint pain was recorded daily, using the articular incapacitation test, until 7 days after ACLT. Solutions or gel preparations of GG (100 microg) or Hylan G-F 20 (100 microg), used as a comparator, were given intraarticularly (i.a.) at day 4 after ACLT. Controls received saline i.a. The OA group had significantly increased joint pain as compared to sham (P<0.001). GG, either as a gel or solution, significantly inhibited joint pain similar to the inhibition achieved with Hylan G-F20. This is the first demonstration that a galactomannan derived from GG reduces joint pain in experimental OA. This analgesia is independent of the colloidal state. We propose that the analgesic benefit of viscosupplementation may be due to an intrinsic carbohydrate-mediated mechanism rather than to the rheologic properties of the material.

Analgesics↗

Synthesis and pharmacological evaluation of some 3-(4-methylphenyl)-2-substituted amino-3H-quinazolin-4-ones as analgesic and anti-inflammatory agents.

A variety of 3-(4-methyl phenyl)-2-substituted amino-3H-quinazolin-4-ones were synthesized by reacting the amino group of 2-hydrazino-3-(4-methyl phenyl)-3H-quinazolin-4-one with a variety of aldehydes and ketones. The starting material 2-hydrazino-3-(4-methyl phenyl)-3H-quinazolin-4-one was synthesized from 4-methyl aniline. The title compounds were investigated for analgesic, anti-inflammatory, and ulcerogenic index activities. While the test compounds exhibited significant activity, compounds Al, A2, and A3 showed more potent analgesic activity and the compound A3 showed more potent anti-inflammatory activity when compared to the reference standard diclofenac sodium. Interestingly, the test compounds showed only mild ulcerogenic potential when compared to aspirin.

Analgesics↗